enow.com Web Search

  1. Ad

    related to: forxiga company

Search results

  1. Results from the WOW.Com Content Network
  2. Dapagliflozin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin

    Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. [ 6 ] [ 7 ] [ 10 ] It is also used to treat adults with heart failure and chronic kidney disease .

  3. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Dapagliflozin, (brand name Forxiga), was approved by the EU in 2012, the first SGLT2 inhibitor approved anywhere. [28] It was approved for use in the United States under the brand name Farxiga in January 2014. [29] Empagliflozin, approved in the United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. [30]

  4. Forxiga ™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes Forxiga, a once-daily oral agent, provides ...

  5. Bristol Myers Squibb - Wikipedia

    en.wikipedia.org/wiki/Bristol_Myers_Squibb

    The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company.Headquartered in Princeton, New Jersey, [2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

  6. AstraZeneca's Forxiga Gets EC Approval for Type-I Diabetes - AOL

    www.aol.com/news/astrazenecas-forxiga-gets-ec...

    AstraZeneca's (AZN) diabetes drug gets approval in Europe for type-1 diabetes as an adjunct to insulin in patients with a BMI greater or equal to 27 kg/m2.

  7. Dapagliflozin/metformin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin/metformin

    To lessen the risk of developing ketoacidosis (a serious condition in which the body produces high levels of blood acids called ketones) after surgery, the FDA has approved changes to the prescribing information for SGLT2 inhibitor diabetes medicines to recommend they be stopped temporarily before scheduled surgery.

  8. AstraZeneca signs $1.92 billion licencing deal with HK-listed ...

    www.aol.com/news/astrazeneca-signs-1-92-billion...

    Apart from the aforementioned milestone and royalty payment, Hong Kong-based CSPC will also get an upfront payment of $100 million as part of the deal. CSPC will develop an early-stage, novel ...

  9. ASEA (American company) - Wikipedia

    en.wikipedia.org/wiki/ASEA_(American_company)

    ASEA is based on technology developed and patented by Medical Discoveries, Inc, a publicly traded company (MLSC). [citation needed] MDI went up for sale in 2007, and board member Verdis Norton secured investment to purchase the technology. Under the company name of ASEA, they began selling the product in 2009 with an official launch in 2010.

  1. Ad

    related to: forxiga company